Concepts (77)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchial Fistula | 1 | 2023 | 24 | 0.800 |
Why?
|
| Pleural Diseases | 1 | 2023 | 32 | 0.790 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2022 | 13 | 0.740 |
Why?
|
| Neoplasms | 3 | 2023 | 2833 | 0.720 |
Why?
|
| Airway Obstruction | 1 | 2022 | 176 | 0.650 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2020 | 192 | 0.550 |
Why?
|
| Albumin-Bound Paclitaxel | 1 | 2015 | 3 | 0.470 |
Why?
|
| Breast Neoplasms | 4 | 2020 | 2586 | 0.440 |
Why?
|
| Thoracentesis | 2 | 2024 | 9 | 0.410 |
Why?
|
| Nanoparticles | 1 | 2015 | 265 | 0.380 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 1750 | 0.300 |
Why?
|
| Pulmonary Medicine | 1 | 2025 | 30 | 0.230 |
Why?
|
| Gravitation | 1 | 2024 | 11 | 0.220 |
Why?
|
| Drainage | 2 | 2024 | 251 | 0.210 |
Why?
|
| Simulation Training | 1 | 2025 | 163 | 0.190 |
Why?
|
| Pleurodesis | 1 | 2022 | 15 | 0.190 |
Why?
|
| Fellowships and Scholarships | 1 | 2025 | 310 | 0.180 |
Why?
|
| Thoracoscopy | 1 | 2022 | 43 | 0.180 |
Why?
|
| Pneumonectomy | 1 | 2023 | 145 | 0.180 |
Why?
|
| Bronchoscopy | 1 | 2022 | 176 | 0.170 |
Why?
|
| Genes, erbB-2 | 1 | 2020 | 32 | 0.170 |
Why?
|
| Education, Medical, Graduate | 1 | 2025 | 505 | 0.170 |
Why?
|
| Critical Care | 1 | 2025 | 659 | 0.160 |
Why?
|
| Bridged-Ring Compounds | 1 | 2018 | 17 | 0.140 |
Why?
|
| Taxoids | 1 | 2018 | 69 | 0.140 |
Why?
|
| Cyclin E | 1 | 2017 | 32 | 0.130 |
Why?
|
| Retinoblastoma Protein | 1 | 2017 | 78 | 0.130 |
Why?
|
| Estrogen Receptor alpha | 1 | 2020 | 419 | 0.130 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2020 | 267 | 0.130 |
Why?
|
| Pyridines | 1 | 2017 | 242 | 0.120 |
Why?
|
| Piperazines | 1 | 2017 | 245 | 0.120 |
Why?
|
| Humans | 10 | 2025 | 125883 | 0.120 |
Why?
|
| Nomograms | 1 | 2015 | 35 | 0.120 |
Why?
|
| Anniversaries and Special Events | 1 | 2015 | 10 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1819 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 204 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 572 | 0.100 |
Why?
|
| Quality of Life | 1 | 2022 | 2008 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 1236 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 5090 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2020 | 4890 | 0.090 |
Why?
|
| Prognosis | 1 | 2020 | 4691 | 0.090 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 425 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1306 | 0.080 |
Why?
|
| Aged | 4 | 2024 | 20022 | 0.080 |
Why?
|
| Middle Aged | 4 | 2024 | 27322 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2023 | 12354 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2020 | 16775 | 0.060 |
Why?
|
| Suction | 1 | 2024 | 50 | 0.050 |
Why?
|
| Adult | 3 | 2020 | 30246 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2024 | 229 | 0.050 |
Why?
|
| Chest Pain | 1 | 2024 | 93 | 0.050 |
Why?
|
| Pleural Effusion | 1 | 2024 | 106 | 0.050 |
Why?
|
| Female | 5 | 2024 | 67886 | 0.050 |
Why?
|
| Curriculum | 1 | 2025 | 754 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2025 | 982 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2017 | 47 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2017 | 62 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2017 | 231 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2018 | 288 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2017 | 250 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 903 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2018 | 377 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2017 | 180 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2017 | 705 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2017 | 584 | 0.030 |
Why?
|
| Receptor, ErbB-2 | 1 | 2018 | 509 | 0.030 |
Why?
|
| Autophagy | 1 | 2017 | 402 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 1343 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 398 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 3465 | 0.020 |
Why?
|
| United States | 1 | 2025 | 11149 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 6571 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 9583 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 17578 | 0.010 |
Why?
|
| Male | 1 | 2024 | 62056 | 0.010 |
Why?
|
| Animals | 1 | 2017 | 33175 | 0.010 |
Why?
|